To further investigate the biological function of SHCBP1 in breast cancer cells, we knocked down SHCBP1 in MCF-7 cell lines, and the efficiency of SHCBP1 knockdown was 68% (P<0.01) (Fig. 3A-C). Here, SHCBP1 is linked to breast carcinoma.